MDR - Biomet Cannulated Screws
Active, not recruiting · NCT04002518
Conditions: Fractures, Bone, Fracture Multiple
At a glance
- Research payments reported, 2025
- $5,061
- U.S. investigators named
- 3
- Sites paid
- 2
- Planned or actual enrollment
- 51
About the trial
- Sponsor
- Zimmer Biomet
- Tested
- Biomet Cannulated Screw: 3.0, 4.0, 5.0, 6.5, and 8.0mm screws. (device)
- Dates
- Started 2019-08-07; completion 2026-10
- Results posted
- Not yet
The objective of this retrospective enrollment/prospective follow up study is to collect data confirming safety, performance, and clinical benefits of the Biomet Cannulated Bone Screw System (Implants and Instrumentation) when used according to the approved Indications for Use (IFU).
From ClinicalTrials.gov, last updated 2026-07-09. Full record, eligibility and contacts (opens in a new tab)
Industry funding
Zimmer Biomet Holdings, Inc. reported $5,061 in research payments for this study in 2025 (4 payments).
Products named: Cannulated Screws
Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.
U.S. investigators named on this study
- Gregory C. Berlet, MD Orthopedic Surgery · Worthington, OH
- Terrence M. Philbin, DO Orthopedic Surgery · Worthington, OH
- Richard Derner, DPM Podiatrists · Lake Ridge, VA
Clinicians the company named as principal investigators in its Open Payments reports.
Sites paid to run it
- Wcg Irb $4,701
- Orthopedic Foot and Ankle Center $360
Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.